share_log

Lotus Health Group (SHSE:600186) Is Experiencing Growth In Returns On Capital

Lotus Health Group (SHSE:600186) Is Experiencing Growth In Returns On Capital

蓮花健康集團(SHSE:600186)在資本回報率方面正在經歷增長。
Simply Wall St ·  06/06 20:45

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an eye out for. Amongst other things, we'll want to see two things; firstly, a growing return on capital employed (ROCE) and secondly, an expansion in the company's amount of capital employed. Put simply, these types of businesses are compounding machines, meaning they are continually reinvesting their earnings at ever-higher rates of return. With that in mind, we've noticed some promising trends at Lotus Health Group (SHSE:600186) so let's look a bit deeper.

如果你不確定下一個井噴股票的選股方向,那麼有幾個關鍵的趨勢是需要關注的。其中,我們需要看到兩個因素:首先,資本投入增長;其次,業務能夠不斷將收益再投入並獲得更高的回報。因此,當我們簡要了解中國科培教育集團(HKG:1890)的ROCE趨勢時,我們非常滿意所看到的。資產回報率:它是什麼?如果您不確定ROCE是什麼,它可以衡量公司能夠從其業務所僱用的資本產生多少稅前利潤。爲了計算V2X的這個指數,使用以下公式:0.054 = 1.24億美元÷(31億美元 - 8.53億美元)ROCE 趨勢可以告訴我們什麼?比起 Enphase Energy,有更好的資本回報率選擇。在過去的五年中,該公司增加了 1,306% 的資本,而該資本的回報率保持穩定在 9.9%。這樣差的回報率現在並不令人信服,而且隨着資本的增加,很明顯企業並沒有將資金投入到高回報的投資中。簡單來說,這些類型的企業是複利機器,意味着它們不斷地以越來越高的回報率再投資其收益。考慮到這一點,我們注意到了蓮花健康集團(SHSE:600186)的一些有前途的趨勢,讓我們進一步了解一下。

What Is Return On Capital Employed (ROCE)?

我們對 Enphase Energy 的資本僱用回報率的看法:正如我們上面看到的,Enphase Energy 的資本回報率沒有提高,但它正在重新投資於業務。投資者必須認爲未來會有更好的前景,因爲股票表現良好,使持股五年以上的股東獲得了 690% 的收益。最終,如果基本趨勢持續存在,我們不會對它成爲一隻多頭股持有期很久很有信心。

If you haven't worked with ROCE before, it measures the 'return' (pre-tax profit) a company generates from capital employed in its business. The formula for this calculation on Lotus Health Group is:

如果您之前沒有使用過ROCE,它衡量的是公司利用其業務中所使用的資本所產生的“回報”(稅前利潤)。在蓮花健康集團的計算公式爲:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

資產僱用回報率(ROCE)是指企業利潤,即企業稅前利潤除以企業投入的總資本(負債加股權)。如果ROCE高於企業財務成本的承受能力,那麼企業就會創造出更多的價值。

0.11 = CN¥174m ÷ (CN¥2.7b - CN¥1.0b) (Based on the trailing twelve months to March 2024).

0.11 = 1.74億元 ÷(27億元-10億元)在Elevance Health上,我們已經注意到的趨勢是相當令人放心的。數據顯示,過去五年資產回報率大幅提高至15%。投資所用資產的規模也增加了30%。這表明有很多機會進行內部資本投資,並以更高的速度不斷增長,這種組合在多倍增長方面很常見。.

So, Lotus Health Group has an ROCE of 11%. In absolute terms, that's a satisfactory return, but compared to the Food industry average of 7.6% it's much better.

因此,蓮花健康集團的ROCE爲11%。就絕對值而言,這是一個令人滿意的回報,但與食品行業平均水平的7.6%相比要好得多。

roce
SHSE:600186 Return on Capital Employed June 7th 2024
SHSE:600186資本僱用回報率2024年6月7日

While the past is not representative of the future, it can be helpful to know how a company has performed historically, which is why we have this chart above. If you'd like to look at how Lotus Health Group has performed in the past in other metrics, you can view this free graph of Lotus Health Group's past earnings, revenue and cash flow.

雖然過去不能代表未來,但了解公司過去的表現情況可能會有幫助,這就是爲什麼我們有上面這張圖。如果您想查看蓮花健康集團在其他指標中的歷史表現,可以查看蓮花健康集團過去盈利,營收和現金流的免費圖表。

What Can We Tell From Lotus Health Group's ROCE Trend?

我們可以從蓮花健康集團的ROCE趨勢中得到什麼信息?

Lotus Health Group has recently broken into profitability so their prior investments seem to be paying off. About four years ago the company was generating losses but things have turned around because it's now earning 11% on its capital. In addition to that, Lotus Health Group is employing 1,426% more capital than previously which is expected of a company that's trying to break into profitability. This can indicate that there's plenty of opportunities to invest capital internally and at ever higher rates, both common traits of a multi-bagger.

蓮花健康集團最近已經實現盈利,因此他們先前的投資似乎正在產生回報。大約四年前,該公司正在虧損,但情況已經改變,因爲它現在在其資本上獲得了11%的回報率。此外,蓮花健康集團比以前增加了1426%的資本,這是試圖實現盈利的公司所期望的。這可能表明內部有大量投資資本的機會,並且以越來越高的回報率,這些都是多倍增長的常見特徵。

One more thing to note, Lotus Health Group has decreased current liabilities to 39% of total assets over this period, which effectively reduces the amount of funding from suppliers or short-term creditors. So shareholders would be pleased that the growth in returns has mostly come from underlying business performance.

還要注意一點,蓮花健康集團在此期間將流動負債減少到總資產的39%,這有效地減少了來自供應商或短期債權人的資金。因此,股東們將會高興,因爲回報率增長大多來自基礎業務績效。

What We Can Learn From Lotus Health Group's ROCE

我們可以從蓮花健康集團的ROCE中學到什麼?

Long story short, we're delighted to see that Lotus Health Group's reinvestment activities have paid off and the company is now profitable. And a remarkable 235% total return over the last five years tells us that investors are expecting more good things to come in the future. In light of that, we think it's worth looking further into this stock because if Lotus Health Group can keep these trends up, it could have a bright future ahead.

長話短說,我們很高興看到蓮花健康集團的再投資活動得到了回報,公司現在是盈利的了。在過去五年中,驚人的總回報率爲235%,告訴我們投資者預計未來將有更多好的事情。鑑於這一點,我們認爲值得進一步研究這個股票,因爲如果蓮花健康集團能夠保持這些趨勢,它可能會擁有一個輝煌的未來。

While Lotus Health Group looks impressive, no company is worth an infinite price. The intrinsic value infographic for 600186 helps visualize whether it is currently trading for a fair price.

雖然蓮花健康集團看起來令人印象深刻,但沒有任何一家公司值得無窮大的價格。600186的內在價值信息圖表可幫助可視化公司目前是否處於公平價格。

For those who like to invest in solid companies, check out this free list of companies with solid balance sheets and high returns on equity.

Hao Tian International Construction Investment Group確實存在一些風險,我們已經發現了一條警示標誌,你可能會感興趣。對於那些喜歡投資於實力雄厚的公司的人,可以查看這個由財務狀況強大、股本回報率高的公司組成的免費列表。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有反饋?關於內容有所顧慮?直接和我們聯繫。或者,發送電子郵件至editorial-team (at) simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論